Quantcast

Latest lung cancer Stories

2014-06-17 04:21:42

Proof-of-Concept Trial Targets DNA Repair in Bile Duct Cancers SAN DIEGO and NEW TAIPEI CITY, Taiwan, June 17, 2014 /PRNewswire-iReach/ -- Senhwa Biosciences, Inc. announced today that the Company has initiated a randomized Phase 1b/2 Trial of CX-4945 in combination with gemcitabine and cisplatin for the frontline treatment of patients with bile duct cancers (cholangiocarcinoma). This Proof-of-Concept trial will study the use of CX-4945, a small molecule CK2 inhibitor, to suppress...

2014-06-16 18:08:50

IASLC Examination and review of several studies that evaluated patient-centered outcomes for individuals undergoing low-dose computed tomography (LDCT) screening for lung cancer found that screening does not appear to significantly influence overall health-related quality of life or result in long-term changes in anxiety or distress, but that positive results in the short-term, do increase distress levels. The National Lung Cancer Screening Trial showed that three annual LDCT screens,...

2014-06-16 16:25:14

Lung-MAP Trial Will Test Five Investigational Approaches, Including Amgen's Rilotumumab, an Investigational Fully Human Monoclonal Antibody THOUSAND OAKS, Calif., June 16, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) announced today that it will collaborate with the National Cancer Institute (NCI), part of the National Institutes of Health, and other public and private sector partners on the Lung Master Protocol (Lung-MAP), a groundbreaking new clinical trial program that will use...

2014-06-13 20:21:28

Father, Advocate, and Seven-Time Lung Cancer Survivor Inspires Awareness WASHINGTON, June 13, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation announces Richard Heimler, seven-time lung cancer survivor and father of two, as the June LUNGevity Hero for his advocacy and awareness-raising. Since his diagnosis in spring 2004, Richard has jumped into action - fighting the disease for a remarkable ten years while also advocating for more funds for important, lifesaving lung cancer research....

2014-06-11 08:31:25

LONDON, June 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Cancer Diagnostic Testing World Marketshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/cancer_diagnostic_testing_world_markets.html Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The National Cancer Institute estimates that about ten million Americans have or have had some form of cancer. Overall costs...

2014-06-11 08:30:00

FLEMINGTON, N.J., June 11, 2014 /PRNewswire/ -- According to the American Cancer Society, lung cancer is the second most common cancer among men and women and the leading cause of death in the United States. In 2014, it is estimated that 224,210 people will be diagnosed with lung cancer. Hunterdon Regional Cancer Center was selected as the only cancer facility in New Jersey to offer a clinical study on a new investigational lung cancer drug called Nivolumab, developed by Bristol-Myers...

2014-06-10 12:30:30

LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Non-small cell lung cancer: Game changing immunotherapies to revolutionise treatment - KOL Insighthttp://www.reportbuyer.com/pharma_healthcare/diseases/non_small_cell_lung_cancer_game_changing_immunotherapies_revolutionise_treatment_kol_insight.html Change is coming to the NSCLC treatment algorithm--and it's coming soon. Revolutionary new immunotherapies, more personalised treatment choices...

2014-06-09 23:09:24

In CHAMPS Oncology's most recent blog post, Cancer Registry on the TODAY Show, Rhonda Spoden shares her thoughts on the topic. Cleveland, OH (PRWEB) June 09, 2014 In CHAMPS Oncology's most recent blog post, Cancer Registry on the TODAY Show, Rhonda Spoden shares her thoughts on the topic. It isn’t often the cancer registry makes national headlines, and (as much as she loves and respects the profession) Spoden never expected to hear about the cancer registry on the TODAY Show....

2014-06-05 16:27:21

LONDON, June 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/research_rd/clinical_trials/squamous_cell_carcinoma_global_clinical_trials_review.html Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, "Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Squamous...

2014-06-03 12:27:34

Institute of Cancer Research Around a quarter of smokers who carry a defect in the BRCA2 gene will develop lung cancer at some point in their lifetime, a large-scale, international study reveals. Scientists announce a previously unknown link between lung cancer and a particular BRCA2 defect, occurring in around 2 per cent of the population, in research published in Nature Genetics today (Sunday). The defect in BRCA2 - best known for its role in breast cancer - increases the risk of...


Latest lung cancer Reference Libraries

Clinical Lung Cancer
2012-05-14 11:09:55

Clinical Lung Cancer is a peer-reviewed medical journal published bimonthly by the CIG Media Group. It was established in 1999. As of May 2012, the editor-in-chief is David R. Gandara. Gandara is a member of the Board of Directors of the International Association for the Study of Lung Cancer and the Addario Foundation. He has also served as a member of the Board of Directors of the American Society of Clinical Oncology (ASCO) and as secretary-treasurer. He is furthermore a member of...

More Articles (1 articles) »
Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin